Circulating angiogenesis‐related biomarkers in sickle cell retinopathy and maculopathy
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70385 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Rajani P Brandsen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Amsterdam UMC, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Retinal Diseases, Angiogenesis, Neovascularization, Pathologic. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Stichting Pupil, Landelijke Stichting voor Blinden en Slechtzienden, Het oogfonds.
Abstract (Originalsprache)
Sickle cell disease (SCD), encompassing genotypes such as HbSS and HbSC, leads to retinal complications such as sickle cell retinopathy (SCR) and maculopathy (SCM) through poorly understood mechanisms. This study explored associations of a panel of circulating angiogenesis‐related factors with SCR and SCM. Adult HbSS (homozygous SCD; n = 33) and HbSC (compound heterozygous SCD; n = 33) patients underwent ophthalmic examination, including optical coherence tomography angiography, to assess SCR stage and presence of SCM. Plasma levels of circulating angiogenesis‐related factors were analysed, with selected markers (angiopoietin‐2, vascular endothelial growth factor [VEGF], granulocyte colony‐stimulating factor, endoglin, endostatin, interleukin [IL]‐6 and IL‐10) assessed using enzyme‐linked immunosorbent assay. Proliferative SCR (PSCR) was present in 5 (15.2%) HbSS and 21 (63.6%) HbSC patients. Foveal avascular zone abnormalities and macular thinning were present in 50.8% and 48.4% of patients respectively. Most vascular factors, including VEGF, showed no association with SCR or SCM. However, angiopoietin‐2 was higher in HbSS patients, independent of SCR stage or SCM, and correlated with IL‐6, IL‐10, VEGF, reticulocyte counts, and lactate dehydrogenase (LDH). In HbSC patients, endostatin levels were highest in those with PSCR ( p = 0.030). While most proteins were unrelated to retinal outcomes, angiopoietin‐2 elevation may reflect HbSS‐specific systemic hypoxia. Elevated endostatin in HbSC patients with PSCR suggests a potential role in PSCR development. These findings offer new leads for understanding SCD‐related retinal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Amsterdam UMC, Amsterdam, the Netherlands.
- Department of Haematology, Amsterdam UMC, Amsterdam, the Netherlands.
- Ocular Angiogenesis Group, Department of Ophthalmology, Amsterdam UMC, Amsterdam, the Netherlands.
- Sanquin Research and Landsteiner Laboratory, Department of Blood Cell Research, Amsterdam, the Netherlands.
- Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland.
Förderung
- Stichting Pupil
- Landelijke Stichting voor Blinden en Slechtzienden
- Het oogfonds
- Stichting Beheer het Schild
- Stichting UitZicht
- Het sikkelcelfonds
- Maarten Kappelle Stichting
- Rotterdamse Stichting Blindenbelangen
Zitieren
APA
Brandsen, R. P., Klaassen, I., de Caluwe, R., Nur, E., Biemond, B. J., Diederen, R. M. H., & Schlingemann, R. O. (2026). Circulating angiogenesis‐related biomarkers in sickle cell retinopathy and maculopathy. British Journal of Haematology. https://doi.org/10.1111/bjh.70385
Vancouver
Brandsen RP, Klaassen I, de Caluwe R, Nur E, Biemond BJ, Diederen RMH, et al. Circulating angiogenesis‐related biomarkers in sickle cell retinopathy and maculopathy. British Journal of Haematology. 2026. doi:10.1111/bjh.70385
BibTeX
@article{Brandsen2026,
author = {Brandsen, Rajani P and Klaassen, Ingeborg and de Caluwe, Renée and Nur, Erfan and Biemond, Bart J and Diederen, Roselie M H and Schlingemann, Reinier O},
title = {Circulating angiogenesis‐related biomarkers in sickle cell retinopathy and maculopathy},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70385}
}
EUVIMED